Literature DB >> 17221294

Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada.

A M Sawka1, A Gafni, P Boulos, K Beattie, A Papaioannou, A Cranney, D A Hanley, J D Adachi, A Cheung, E A Papadimitropoulos, L Thabane.   

Abstract

UNLABELLED: Hip fractures are an important problem in nursing homes. Hip protectors are external devices that decrease the risk of hip fracture in elderly nursing home residents. We estimated the overall healthcare cost savings from a hypothetical strategy of provision of hip protectors to elderly nursing home residents in Ontario, Canada. In a recent meta-analysis, we determined that a strategy of provision of hip protectors decreases the risk of hip fracture in nursing home residents.
INTRODUCTION: Our objective was to determine whether the provision of hip protectors to all Ontario nursing home residents aged > or =65 years could result in cost savings, stemming from reductions in initial hospitalizations for hip fracture.
METHODS: We conducted a cost analysis from a Ministry of Health perspective (one year cycle length). The efficacy of the intervention was estimated from a meta-analysis of randomized controlled trials.
RESULTS: A strategy of provision of hip protectors to all 60,775 elderly Ontario nursing home residents could result in an overall mean cost savings of 6.0 million Canadian dollars in one year (95% credibility interval, -26.4 million, 39.7 million), with a probability of cost savings of 0.63 (assuming no additional labor costs). In sensitivity analyses, decreasing hip protector price increased cost savings, whereas additional labor expenditures for application for hip protectors decreased cost savings.
CONCLUSION: In conclusion, if hip protectors can be provided to elderly Ontario nursing home residents without additional labor expenditures, there is a reasonable probability that such a strategy may result in healthcare cost savings.

Entities:  

Mesh:

Year:  2007        PMID: 17221294     DOI: 10.1007/s00198-006-0307-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  43 in total

Review 1.  Cost-effectiveness of hip protectors in institutional dwelling elderly.

Authors:  Lisa Waldegger; Ann Cranney; Malcolm Man-Son-Hing; Doug Coyle
Journal:  Osteoporos Int       Date:  2003-04-10       Impact factor: 4.507

2.  Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Health Policy       Date:  2003-05       Impact factor: 2.980

3.  An in-service evaluation of hip protector use in residential homes.

Authors:  Paul Thompson; Carol Jones; Adrian Dawson; Peter Thomas; Tracy Villar
Journal:  Age Ageing       Date:  2005-01       Impact factor: 10.668

4.  Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial.

Authors:  D W Molloy; G H Guyatt; R Russo; R Goeree; B J O'Brien; M Bédard; A Willan; J Watson; C Patterson; C Harrison; T Standish; D Strang; P J Darzins; S Smith; S Dubois
Journal:  JAMA       Date:  2000-03-15       Impact factor: 56.272

5.  Economic implications of hip fracture: health service use, institutional care and cost in Canada.

Authors:  M E Wiktorowicz; R Goeree; A Papaioannou; J D Adachi; E Papadimitropoulos
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

6.  Fracture risk in patients with Alzheimer's disease.

Authors:  L J Melton; C M Beard; E Kokmen; E J Atkinson; W M O'Fallon
Journal:  J Am Geriatr Soc       Date:  1994-06       Impact factor: 5.562

7.  Prevention of hip fractures by external hip protectors: a randomized controlled trial.

Authors:  Natasja M van Schoor; Johannes H Smit; Jos W R Twisk; Lex M Bouter; Paul Lips
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

8.  Force attenuation properties of various trochanteric padding materials under typical falling conditions of the elderly.

Authors:  J Parkkari; P Kannus; J Poutala; I Vuori
Journal:  J Bone Miner Res       Date:  1994-09       Impact factor: 6.741

Review 9.  Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis.

Authors:  Anna M Sawka; Pauline Boulos; Karen Beattie; Alexandra Papaioannou; Amiram Gafni; Ann Cranney; David A Hanley; Jonathan D Adachi; E A Papadimitropoulos; Lehana Thabane
Journal:  J Clin Epidemiol       Date:  2006-10-23       Impact factor: 6.437

10.  Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.

Authors:  Sonia Singh; Huiying Sun; Aslam H Anis
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

View more
  5 in total

1.  Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.

Authors:  B Stollenwerk; T Bartmus; F Klug; S Stock; D Müller
Journal:  Osteoporos Int       Date:  2015-01-09       Impact factor: 4.507

Review 2.  Prevention of osteoporosis-related fractures among postmenopausal women and older men.

Authors:  Poupak Rahmani; Suzanne Morin
Journal:  CMAJ       Date:  2009-10-19       Impact factor: 8.262

Review 3.  Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk.

Authors:  R T A L de Bot; H D Veldman; A M Witlox; L W van Rhijn; M Hiligsmann
Journal:  Osteoporos Int       Date:  2020-02-10       Impact factor: 4.507

4.  Cost-effectiveness of injury prevention - a systematic review of municipality based interventions.

Authors:  Harald Gyllensvärd
Journal:  Cost Eff Resour Alloc       Date:  2010-09-10

5.  Validation and psychometric properties of the commitment to hip protectors (C-HiP) index in long-term care providers of British Columbia, Canada: a cross-sectional survey.

Authors:  Alexandra M B Korall; Judith Godin; Fabio Feldman; Ian D Cameron; Pet-Ming Leung; Joanie Sims-Gould; Stephen N Robinovitch
Journal:  BMC Geriatr       Date:  2017-05-03       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.